Prognostic Factors and Surgical Approaches in Gastric Cancer

Summary

Gastric cancer remains a leading cause of cancer mortality worldwide, with outcomes determined by a complex interplay of tumour biology, host factors and the extent of surgical intervention. Established prognostic indicators include TNM stage, depth of invasion, nodal status and the presence of lymphovascular or perineural invasion, each reflecting the propensity for dissemination and recurrence. Molecular subtypes—such as those defined by histological classifications and emerging genomic signatures—offer further stratification, guiding tailored systemic therapies. Radiological biomarkers, including computed-tomography-derived features of extramural venous invasion, are gaining traction as non-invasive predictors of response to immunotherapy and long-term survival. Nutritional status and patient performance also influence outcome by affecting postoperative recovery and tolerance of adjuvant treatments.

Surgical management has evolved from radical open gastrectomy to a spectrum of interventions matched to disease stage. Early lesions confined to the mucosa can be treated with endoscopic resection techniques, while locally advanced tumours demand gastrectomy with systematic lymphadenectomy, typically following a D2 template. The choice between total, proximal or subtotal gastrectomy hinges on tumour location and aims to preserve function without compromising oncological clearance. Attention to resection margins—3 cm for expansive and 5 cm for infiltrative growth patterns—ensures adequate local control. Reconstruction following gastrectomy varies, with Roux-en-Y being most common, although pouch and other variants may improve quality of life. Minimally invasive approaches, including laparoscopic and robotic gastrectomy, have demonstrated equivalent oncological outcomes with reduced postoperative morbidity. In selected cases of oligometastatic disease, synchronous resection of primary tumour and metastases after systemic therapy is under investigation to extend survival.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Prognostic Factors and Surgical Approaches in Gastric Cancer publication trend

The graph below shows the total number of articles in prognostic factors and surgical approaches in gastric cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Perineural invasion (PNI): Tumour cell infiltration along nerve sheaths, linked to immune modulation and poorer prognosis.

Lymphovascular invasion (LVI): Presence of cancer cells in lymphatic or blood vessels, indicating higher metastatic risk.

D2 lymphadenectomy: Systematic removal of perigastric and second-tier regional lymph nodes during gastrectomy.

Endoscopic submucosal dissection (ESD): Minimally invasive removal of early gastric neoplasms confined to mucosa or superficial submucosa.

Roux-en-Y reconstruction: Technique to restore gastrointestinal continuity after gastrectomy, reducing bile reflux and improving nutrition.

References

  1. Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment. Journal of Experimental & Clinical Cancer Research (2023).
  2. Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer. JAMA Network Open (2023).
  3. Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer. Journal of Translational Medicine (2023).
  4. Surgery Matters: Progress in Surgical Management of Gastric Cancer. Current Treatment Options in Oncology (2023).
  5. Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology. Oncotarget (2018).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.